Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Mar Drugs ; 22(2)2024 Feb 14.
Article in English | MEDLINE | ID: mdl-38393059

ABSTRACT

Anithiactin D (1), a 2-phenylthiazole class of natural products, was isolated from marine mudflat-derived actinomycetes Streptomyces sp. 10A085. The chemical structure of 1 was elucidated based on the interpretation of NMR and MS data. The absolute configuration of 1 was determined by comparing the experimental and calculated electronic circular dichroism (ECD) spectral data. Anithiactin D (1) significantly decreased cancer cell migration and invasion activities at a concentration of 5 µM via downregulation of the epithelial-to-mesenchymal transition (EMT) markers in A549, AGS, and Caco-2 cell lines. Moreover, 1 inhibited the activity of Rho GTPases, including Rac1 and RhoA in the A549 cell line, suppressed RhoA in AGS and Caco-2 cell lines, and decreased the mRNA expression levels of some matrix metalloproteinases (MMPs) in AGS and Caco-2 cell lines. Thus 1, which is a new entity of the 2-phenylthiazole class of natural products with a unique aniline-indole fused moiety, is a potent inhibitor of the motility of cancer cells.


Subject(s)
Neoplasms , Streptomyces , Humans , Cell Line, Tumor , Caco-2 Cells , Streptomyces/metabolism , A549 Cells , rho GTP-Binding Proteins/metabolism , Cell Movement , Epithelial-Mesenchymal Transition
2.
Int J Mol Sci ; 23(1)2022 Jan 05.
Article in English | MEDLINE | ID: mdl-35008995

ABSTRACT

The present study investigated the effects of interleukin (IL)-4 on striatal neurons in lipopolysaccharide (LPS)-injected rat striatum in vivo. Either LPS or PBS as a control was unilaterally injected into the striatum, and brain tissues were processed for immunohistochemical and Nissl staining or for hydroethidine histochemistry at the indicated time points after LPS injection. Analysis by NeuN and Nissl immunohistochemical staining showed a significant loss of striatal neurons at 1, 3, and 7 days post LPS. In parallel, IL-4 immunoreactivity was upregulated as early as 1 day, reached a peak at 3 days, and was sustained up to 7 days post LPS. Increased levels of IL-4 immunoreactivity were exclusively detected in microglia/macrophages, but not in neurons nor astrocytes. The neutralizing antibody (NA) for IL-4 significantly protects striatal neurons against LPS-induced neurotoxicity in vivo. Accompanying neuroprotection, IL-4NA inhibited activation of microglia/macrophages, production of reactive oxygen species (ROS), ROS-derived oxidative damage and nitrosative stress, and produced polarization of microglia/macrophages shifted from M1 to M2. These results suggest that endogenous IL-4 expressed in LPS-activated microglia/macrophages contributes to striatal neurodegeneration in which oxidative/nitrosative stress and M1/M2 polarization are implicated.


Subject(s)
Interleukin-4/metabolism , Lipopolysaccharides/adverse effects , Microglia/immunology , Microglia/metabolism , Oxidative Stress , Striatonigral Degeneration/etiology , Striatonigral Degeneration/metabolism , Animals , Biomarkers , Corpus Striatum/metabolism , Corpus Striatum/pathology , Disease Models, Animal , Disease Susceptibility , Female , Immunohistochemistry , Lipopolysaccharides/immunology , Macrophage Activation/immunology , Macrophages/immunology , Macrophages/metabolism , Microglia/drug effects , Oxidative Stress/drug effects , Rats , Striatonigral Degeneration/pathology
3.
Mar Drugs ; 20(1)2021 Dec 29.
Article in English | MEDLINE | ID: mdl-35049890

ABSTRACT

Analysis of the chemical components from the culture broth of the marine bacterium Saccharomonospora sp. CNQ-490 has yielded three novel compounds: saccharobisindole (1), neoasterric methyl ester (2), and 7-chloro-4(1H)-quinolone (3), in addition to acremonidine E (4), pinselin (5), penicitrinon A (6), and penicitrinon E (7). The chemical structures of the three novel compounds were elucidated by the interpretation of 1D, 2D nuclear magnetic resonance (NMR), and high-resolution mass spectrometry (HRMS) data. Compound 2 generated weak inhibition activity against Bacillus subtilis KCTC2441 and Staphylococcus aureus KCTC1927 at concentrations of 32 µg/mL and 64 µg/mL, respectively, whereas compounds 1 and 3 did not have any observable effects. In addition, compound 2 displayed weak anti-quorum sensing (QS) effects against S. aureus KCTC1927 and Micrococcus luteus SCO560.


Subject(s)
Actinobacteria , Anti-Bacterial Agents/pharmacology , Quinolones/pharmacology , Animals , Anti-Bacterial Agents/chemistry , Aquatic Organisms , Bacillus subtilis/drug effects , Esters , Humans , Microbial Sensitivity Tests , Quinolones/chemistry
4.
Mar Drugs ; 18(9)2020 Sep 10.
Article in English | MEDLINE | ID: mdl-32927886

ABSTRACT

Many bioactive materials have been isolated from marine microorganisms, including alkaloids, peptides, lipids, mycosporine-like amino acids, glycosides, and isoprenoids. Some of these compounds have great potential in the cosmetic industry due to their photo-protective, anti-aging, and anti-oxidant activities. In this study, sarmentosamide (1) was isolated from marine-derived Streptomyces sp. APmarine042, after which its capacity to decrease skin aging was examined in-vitro. Sarmentosamide (1) was found to significantly reduce UVB-induced matrix metalloproteinase-1 (MMP-1) expression in normal human dermal fibroblasts (NHDFs) by inhibiting the extracellular signal-regulated kinase (ERK) and the c-Jun N-terminal kinase (JNK) phosphorylation, which are regulatory pathways upstream of MMP-1 transcription. Additionally, we confirmed that sarmentosamide (1) decreased tumor necrosis factor-alpha (TNF-α), induced MMP-1 secretion in NHDFs, and exhibited free-radical scavenging activity, as demonstrated by 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. Therefore, our study suggests that sarmentosamide (1) could be a promising anti-aging agent that acts via the downregulation of MMP-1 expression.


Subject(s)
Fibroblasts/drug effects , Matrix Metalloproteinase 1/metabolism , Matrix Metalloproteinase Inhibitors/pharmacology , Skin Aging/drug effects , Skin/drug effects , Streptomyces/metabolism , Cell Line , Extracellular Signal-Regulated MAP Kinases/metabolism , Fibroblasts/metabolism , Fibroblasts/pathology , Fibroblasts/radiation effects , Free Radical Scavengers/chemistry , Free Radical Scavengers/isolation & purification , Free Radical Scavengers/pharmacology , Geologic Sediments/microbiology , JNK Mitogen-Activated Protein Kinases/metabolism , Matrix Metalloproteinase 1/genetics , Matrix Metalloproteinase Inhibitors/chemistry , Matrix Metalloproteinase Inhibitors/isolation & purification , Molecular Structure , Phosphorylation , Skin/metabolism , Skin/pathology , Skin/radiation effects , Skin Aging/radiation effects , Tumor Necrosis Factor-alpha/metabolism
5.
Pharm Biol ; 58(1): 716-720, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32697127

ABSTRACT

CONTEXT: Research interest in monoamine oxidase (MAO) as a promising drug target for neurodegenerative diseases has a long history. However, efforts to develop MAO inhibitors (MAOIs) from marine sources have been limited, despite the increasing number of interesting marine natural products. OBJECTIVE: To review the potential of marine natural products as MAOIs source, including their activities and selectivity on MAO. METHODS: Public databases such as SciFinder, MarinLit and PubMed were systematically searched from 1991 until Dec 2019. MAO and MAOI were the key terms searched combined with marine natural products and marine. RESULTS: Six classes of marine natural products with good selectivity between the two MAO subtypes were organized with their selectivity and sources. CONCLUSIONS: This is the first review to investigate the potential of marine natural products as MAOIs source. Despite the small number of known MAOIs from marine sources, marine natural products are potential leads for the further development of MAOI drugs with novel chemical frames and good selectivity.


Subject(s)
Biological Products/isolation & purification , Monoamine Oxidase Inhibitors/isolation & purification , Neurodegenerative Diseases/drug therapy , Animals , Aquatic Organisms , Biological Products/pharmacology , Drug Development , Humans , Monoamine Oxidase Inhibitors/pharmacology , Neurodegenerative Diseases/physiopathology
6.
Int J Biol Macromol ; 137: 426-432, 2019 Sep 15.
Article in English | MEDLINE | ID: mdl-31271801

ABSTRACT

Six synthetic (1-6) and six natural (7-12) chalcones were tested for human monoamine oxidases (hMAOs) and acetylcholinesterase (AChE) inhibitory activities. Compounds 4-dimethylaminochalcone (2), 4'-chloro-4-dimethylaminochalcone (5), and 2,4'-dichloro-4-dimethylaminochalcone (1) potently inhibited hMAO-B with IC50 values of 0.029, 0.061, and 0.075 µM, respectively. 4-Nitrochalcone (4) and 4-chlorochalcone (3) also potently inhibited hMAO-B with IC50 values of 0.066 and 0.082 µM, respectively (2.3- and 2.6-fold less than compound 2). Compound 2 had a high selectivity index (113.1) for hMAO-B over hMAO-A (IC50 = 3.28 µM). Compounds 1 and 2,2'-dihydroxy-4',6'-dimethoxychalcone (12) potently inhibited hMAO-A with IC50 values of 0.18 and 0.39 µM, respectively. In addition, compounds 4 and 2 also effectively inhibited AChE with IC50 values of 1.25 and 6.07 µM, respectively, and thus, exhibited dual-targeting. Compound 2 reversibly and competitively inhibited hMAO-B with a Ki value of 0.0066 µM. Docking simulations showed binding affinities of compounds 1 to 5 for hMAO-B were higher than those for hMAO-A or AChE and suggested these five chalcones form hydrogen bonds with MAO-B at Cys172 but that they do not form hydrogen bonds with hMAO-A or AChE. These findings suggest compound 2 be considered a promising and dual-targeting lead compound for the treatment of Alzheimer's disease.


Subject(s)
Chalcones/chemistry , Chalcones/pharmacology , Monoamine Oxidase Inhibitors/chemistry , Monoamine Oxidase Inhibitors/pharmacology , Monoamine Oxidase/metabolism , Chalcones/metabolism , Humans , Molecular Docking Simulation , Monoamine Oxidase/chemistry , Monoamine Oxidase Inhibitors/metabolism , Protein Conformation
7.
Mar Drugs ; 17(2)2019 Feb 02.
Article in English | MEDLINE | ID: mdl-30717397

ABSTRACT

A cytotoxic alkaloidal meroterpenoid, saccharoquinoline (1), has been isolated from the fermentation broth of the marine-derived bacterium Saccharomonospora sp. CNQ-490. The planar structure of 1 was elucidated by 1D, 2D NMR, and MS spectroscopic data analyzes, while the relative configuration of 1 was defined through the interpretation of NOE spectroscopic data. Saccharoquinoline (1) is composed of a drimane-type sesquiterpene unit in combination with an apparent 6,7,8-trihydroxyquinoline-2-carboxylic acid. This combination of biosynthetic pathways was observed for the first time in natural microbial products. Saccharoquinoline (1) was found to have cytotoxicity against the HCT-116 cancer cell line by inducing G1 arrest, which leads to cell growth inhibition.


Subject(s)
Actinobacteria/metabolism , Antineoplastic Agents/pharmacology , Terpenes/chemistry , Terpenes/pharmacology , Actinobacteria/chemistry , Antineoplastic Agents/chemistry , Cell Line, Tumor , Cell Survival/drug effects , Humans , Models, Molecular , Molecular Structure
8.
Molecules ; 23(12)2018 Dec 03.
Article in English | MEDLINE | ID: mdl-30513974

ABSTRACT

Intensive study on the chemical components of a Korean marine sponge, Spongia sp., has led to the isolation of four new scalarane sesterterpenes, scalalactams A⁻D (1⁻4). Their chemical structures were elucidated from the analysis of spectroscopic data including 1D-and 2D-NMR as well as MS data. Scalalactams A⁻D (1⁻4) possess a scalarane carbon skeleton with a rare structural feature of a γ-lactam moiety within the molecules. Scalalactams A and B (1 and 2) have an extended isopropanyl chain at the lactam ring, and scalalactams C and D (3 and 4) possess a phenethyl group at the lactam ring moiety. Scalalactams A⁻D (1⁻4) did not show FXR antagonistic activity nor cytotoxicity up to 100 µM.


Subject(s)
Porifera/chemistry , Sesterterpenes/chemistry , Sesterterpenes/pharmacology , Animals , Aquatic Organisms/chemistry , Drug Evaluation, Preclinical/methods , Humans , Lactams/chemistry , Magnetic Resonance Spectroscopy , Molecular Structure , Receptors, Cytoplasmic and Nuclear/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...